Corton Capital Inc. Roivant Sciences Ltd. Transaction History

Corton Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.36 - $11.74 $763,635 - $865,355	-73,710 Reduced 83.88%	14,161 $149,000
Q1 2024 May 15, 2024	BUY	$9.87 - $11.8 $492,700 - $589,044	49,919 Added 131.53%	87,871 $926,000
Q4 2023 Feb 14, 2024	BUY	$8.38 - $11.58 $89,800 - $124,091	10,716 Added 39.34%	37,952 $426,000
Q3 2023 Nov 14, 2023	BUY	$9.76 - $13.19 $123,805 - $167,315	12,685 Added 87.18%	27,236 $318,000
Q2 2023 Aug 14, 2023	BUY	$7.09 - $10.08 $103,166 - $146,674	14,551 New	14,551 $146,000

312

507M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $7.49B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.